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Mutations in ZFHX1B cause Mowat–Wilson syndrome (MWS) but the precise mechanisms underlying the
aberrant functions of mutant ZFHX1B proteins (also named Smad-interacting protein-1, SIP1) in patients
are unknown. Using mass spectrometry analysis, we identified subunits of the NuRD corepressor complex
in affinity-purified Zfhx1b complexes. We find that Zfhx1b associates with NuRD through its N-terminal
domain, which contains a previously postulated NuRD interacting motif. Interestingly, this motif is substi-
tuted by an unrelated sequence in a recently described MWS patient. We show here that such aberrant
ZFHX1B protein is unable to recruit NuRD subunits and displays reduced transcriptional repression activity
on the XBMP4 gene promoter, a target of Zfhx1b. We further demonstrate that the NuRD component Mi-2b is
involved in repression of the Zfhx1b target gene E-cadherin as well as in Zfhx1b-induced neural induction in
animal caps from Xenopus embryos. Thus, NuRD and Zfhx1b functionally interact, and defective NuRD
recruitment by mutant human ZFHX1B can be a MWS-causing mechanism. This is the first study providing
mechanistic insight into the aberrant function of a single domain of the multi-domain protein ZFHX1B/SIP1
in human disease.
INTRODUCTION
Loss-of-heterozygosity of ZFHX1B (encoding ZFHX1B, Zinc
finger homeobox 1B, also named SIP1 and ZEB2) is implicated
in the etiology of Mowat–Wilson syndrome (MWS). All
patients with typical MWS present severe mental retardation
and display distinctive facial dysmorphism in addition to mul-
tiple variable features, including heart defects, agenesis of the
corpus callosum, seizures, urogenital anomalies and Hirsch-
sprung disease (1). Analysis of the phenotype of Zfhx1b con-
ventional knockout mouse embryos revealed defects in the
neural crest cell lineage (2,3). In addition, the reduced
expression of the neuroectodermal gene Sox2 and the sustained
expression of E-cadherin in the Zfhx1b defective neural plate
indicated defects in early neurogenesis in these embryos (2).
Both classes of defect are relevant to the neurological problems
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seen in MWS patients. Zfhx1b was also found to be a crucial
regulator of early neural tissue formation in Xenopus (4).
We have identified Zfhx1b as a protein that binds to TGFb
family receptor activated Smad proteins and acts as a DNA-
binding transcriptional repressor (5,6). After dEF1 (Zfhx1a),
Zfhx1b became the second and only other member of the
Zfhx1 family in vertebrates. These multi-domain repressors
are characterized by the presence of a homeodomain-like
domain and two flanking C2H2-type zinc finger clusters.
Both clusters are necessary for Zfhx1b to repress target
genes by binding to spaced CACCT(G) sequences in their
regulatory region (6). Though studies have focused mainly
on Zfhx1b repressive function, transcriptional activation
activity has been ascribed to Zfhx1b as well (7,8). Indeed,
Zfhx1b interacts not only with the corepressor CtBP
(C-terminal binding protein) (9,10), but full-length Zfhx1b
also binds to the coactivators p300 and pCAF (p300/CBP
associated factor) (11). Taken together, Zfhx1-type proteins
are complex multi-domain proteins: not all of their functions
may depend on interaction with Smad proteins, and associ-
ation with different partners via different domains may
provide selectivity for target gene repression or activation.
The vast majority of the clinically characterized human
mutations are all gene deletions, nonsense or frame shift
mutations affecting a single allele. In nearly all cases, this
leads to drastic C-terminal truncation of ZFHX1B in
humans, and possibly instability of the protein (12). Recently,
also non-truncating mutations in ZFHX1B in patients present-
ing with a mild form of MWS have been identified, leading to
the assumption of a possible correlation between more subtle
mutations and a milder or atypical phenotype (13–16).
Despite the emerging list of mapped truncating and non-
truncating mutations in ZFHX1B, the precise molecular mech-
anism(s) underlying the clinical features of MWS patients car-
rying these mutations are still unknown. In a global approach
to address Zfhx1b’s mechanism(s) of action, we decided to
purify Zfhx1b protein complexes and identify candidate
Zfx1b direct binding partners or proteins in its complex by
mass spectrometry (MS). Doing so, we found a novel associ-
ation of Zfhx1b with multiple subunits of the nucleosome
remodeling and histone deacetylation complex NuRD.
NuRD is composed of at least eight subunits, including the
ATPase Mi-2b, which confers the chromatin remodeling
activity (17). NuRD has been purified from both mammalian
and amphibian cells and is considered to play a key role in
transcriptional repression (18–21). Results from our study
allow us to propose defective NuRD recruitment by Zfhx1b
as part of Zfhx1b’s mechanism of action and—here—as an
underlying cause of a form of MWS.
RESULTS
Affinity purified Zfhx1b complexes contain multiple
NuRD subunits
We generated a tagged Zfhx1b protein in which a strep tag (S)
is preceded by a 3XFlag epitope (F) at the N-terminus
(Fig. 1A). Protein complexes containing this 3XFS-Zfhx1b
were isolated by means of a variant tandem affinity purifi-
cation approach (Fig. 1B). Briefly, total extracts of human
embryonic kidney (HEK293T) cells transiently producing
3XFS-Zfhx1b proteins were subjected to anti-Flag agarose
affinity gel-based purification. Following elution with excess
3XFlag peptide, the eluted proteins were applied to a streptac-
tin agarose column as a second purification step. After gel
electrophoresis and staining of the proteins, the bands were
excised and the polypeptides were identified by MS
(Fig. 1C). The major polypeptide, migrating as a protein of
170 kDa present in the purified 3XFS-Zfhx1b sample, was
shown to correspond with 3XFS-Zfhx1b. Amongst the pro-
teins that copurified with Zfhx1b were the known partners
CtBP1 and -2 (9,10). Additionally, we identified novel
Zfhx1b partners that are subunits of the NuRD complex, i.e.
Mi-2b, p66b, the metastasis associated proteins MTA1, -2
and -3, the histone deacetylases HDAC1 and -2, and the reti-
noblastoma associated protein RbAp48.
Zfhx1b associates with NuRD
The identification of many subunits of NuRD in Zfhx1b com-
plexes made us focus on a role of NuRD as a novel cofactor
for Zfhx1b that is possibly involved in Zfhx1b-dependent
repression. We therefore probed for Zfhx1b association with
endogenous NuRD subunits. For this, we performed a Flag-
based purification of extracts of HEK293T cells containing
transiently produced 3XFS-Zfhx1b proteins (or only 3XFS
Figure 1. Tandem affinity purified Zfhx1b complexes contain multiple sub-
units of NuRD. (A) Graphic presentation of the mouse Zfhx1b protein and
the N-terminally 3XFS-tagged variant. The N-terminal and C-terminal zinc
finger domains (NZF and CZF), Smad-binding domain (SBD), homeodomain-
like domain (HD), the C3H type zinc finger (light grey box) and the CtBP
interacting sites (CBS) are shown. (B) Schematic representation of the
variant tandem affinity purification procedure. The first purification involves
an in-batch Flag-IP of extracts of HEK293T cells, containing transiently syn-
thesized 3XFS-Zfhx1b proteins. Upon elution with 3XFLAG peptides, the
eluted proteins were applied to a streptactin-agarose column for a second puri-
fication. Precipitation was done using acetone. (C) Brilliant blue G-colloidal
staining of the purified proteins from HEK293T cells transiently producing
3XFS-Zfhx1b or 3XFS-tag only. Co-purified proteins were identified by MS.
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tag as control). Western-blot analysis using NuRD subunit-
specific antibodies confirmed the association of Zfhx1b with
all the subunits identified by MS, with the exception of
p66b (Fig. 2A). Also RbAp46 of the NuRD complex
co-purified with 3XFS-Zfhx1b. Subsequently, the interaction
of endogenous Zfhx1b with endogenous NuRD subunits was
analyzed by subjecting extracts of HEK293T cells to immuno-
precipitation using anti-Zfhx1b antiserum. WB analysis
showed that endogenous Zfhx1b associated with Mi-2b,
MTA1, MTA2, HDAC1 and RbAp48 (Fig. 2B). None of the
NuRD subunits were detected when extracts were incubated
with control antibody. Hence, our results show that Zfhx1b
associates with the NuRD complex at normal physiological
levels. Similarly, we have also observed interaction between
dEF1 and several NuRD subunits (data not shown).
Mi-2b is a specific cofactor for Zfhx1b-mediated
transcriptional repression of E-cadherin promoter
Zfhx1b represses E-cadherin transcription in epithelial cells in
culture, and an inverse correlation is seen between Zfhx1b and
E-cadherin mRNA (as well as their protein levels) in cells of
epithelium derived tumors (22). We previously observed a
persistence of E-cadherin mRNA and protein in the neuroe-
pithelium of Zfhx1b knockout mouse embryos, which has
been linked with the neurological problems seen in MWS
patients (2). These observations, together with DNA-binding
data in vitro, make the E-cadherin gene a direct target for
Zfhx1 proteins (6,10). To address a potential role for NuRD
in Zfhx1b-regulated E-cadherin transcription, we included a
mutant NuRD component, Mi-2bK750C, in an E-cadherin
promoter-based reporter assay. Mi-2bK750C contains a
mutation within its ATPase domain and was shown recently
to act in a dominant-negative manner with respect to
Mi-2b’s involvement in NAB2-mediated repression (29).
We found that the level of repression by Zfhx1b of E-cadherin
promoter-based reporter constructs was reduced in the pre-
sence of Mi-2bK750C, whereas Mi-2bK750C alone did not
have a substantial effect on this reporter (Fig. 3A). Over-
expression of wild-type Mi-2b restored Zfhx1b-mediated tran-
scriptional repression of the reporter construct (Fig. 3A).
3TPlux, which is another Zfhx1b-sensitive reporter (6), was
not affected in the presence of Mi-2bK750C (Fig. 3B).
These results demonstrate that Mi-2b can function as a
target gene-specific corepressor of Zfhx1b.
A mutant Zfhx1b protein causing atypical MWS
is unable to interact with NuRD
To identify the domain of Zfhx1b necessary for association
with NuRD, a series of Zfhx1b deletion mutants (from
mouse, Fig. 4A) were transiently produced and tested for inter-
action with MTA2, HDAC2 and RbAp48. As shown in
Figure 4B, all peptides containing at least the Zfhx1b
N-terminal domain co-precipitated with these subunits, whereas
a long Zfhx1b polypeptide (from amino acid 715 till 1214)
did not. Hence, the first 289 amino acids of Zfhx1b were
found to be sufficient for interaction with the NuRD subunits
tested here. An N-terminally 12 amino acid-long motif was
recently found to be necessary and sufficient for NuRD
recruitment by the transcriptional repressor Sall1 (30). Most
notably, the critical residues within this motif that, upon sub-
stitution, abolished NuRD binding and decreased transcrip-
tional repression by Sall1, are fully conserved within the
Zfhx1b N-terminal domain. This putative NuRD-binding
motif is also strongly conserved in Zfhx1b orthologues,
including in H. sapiens and X. laevis (Fig. 5A; bold type
sequences), as well as in dEF1.
A ZFHX1B mutation disrupting a splice site was recently
identified in a patient presenting a mild form of MWS. The
resulting protein was found to be identical to ZFHX1B
except for the first 24 amino acids, which in this patient
were replaced by a heterologous sequence (16). Alignment
of wild-type and mutant sequences shows that this atypical
ZFHX1B protein (referred to as AZmut) lacks the NuRD inter-
action motif (Fig. 5A). To test this experimentally, we gener-
ated a construct encoding a similar ZFHX1B mutant protein
(see Fig. 5B), and probed for interaction with endogenous
NuRD subunits. To this end, HEK293T cells extracts contain-
ing either transiently produced 3XFS-ZFHX1BWT or
3XFS-ZFHX1BAZmut proteins were subjected to immunopre-
cipitation with anti-Flag antibodies. Western-blot analysis
using NuRD subunit-specific antibodies revealed defective
NuRD association by ZFHX1BAZmut proteins, whereas CtBP
binding was unaffected (Fig. 5C). Immuofluorescence analysis
showed that wild-type as well as mutant ZFHX1B proteins
both localize to the nucleus of HeLa cells (data not shown).
Together, these findings support the importance of the
Figure 2. Zfhx1b associates with several subunits of the NuRD complex. (A)
Extracts of HEK293T cells containing transiently synthesized 3XFS-Zfhx1b
or 3XFS tag as negative control were precipitated in a Flag-dependent
manner and eluted using 3XFLAG peptides. Western-blot analysis was per-
formed using antibodies directed against the NuRD subunits. (B) IP of
HEK293T cell extracts with Zfhx1b-specific or control anti-Flag antibodies,
followed by Western-blot analysis using NuRD subunit-specific antibodies.
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conserved motif for NuRD recruitment by Zfhx1b protein, and
further suggest defective NuRD recruitment by mutant
ZFHX1B human protein as the underlying cause of this atypi-
cal MWS in this patient (16).
XMi-2b is involved in XZfhx1b-induced neural
tissue formation
Zfhx1b plays an essential role in early neural development in
the amphibian embryo (4). We therefore also used Xenopus as
a model to investigate a potential role for NuRD in XZfhx1b’s
neural inducing activity. First, we addressed whether the
expression domain of endogenous XMi-2b overlaps with that
of XZfhx1b during Xenopus embryogenesis. In situ hybridiz-
ation analysis showed that XMi-2b mRNA, like XZfhx1b, is
initially broadly expressed at gastrula stage, whereas at
neurula stage it becomes more strongly expressed in neural
tissue and neural crest cells. At tadpole stage, the strong
expression of XMi-2b and XZfhx1b mRNA persists in the
neural tube and also in neural crest cells and, also similar to
mouse Zfhx1b mRNA, in the somites, in line with its docu-
mented role in somitogenesis (Fig. 6A) (31). This specific
expression pattern thus supports a role for XMi-2b in early
neurogenesis, while the strong overlap between XZfhx1b and
XMi-2b RNA expression suggests that the encoded proteins
may indeed act together in neural development and possibly
somitogenesis.
Part of XZfhx1b’s neuralizing activity can be ascribed to the
transcriptional repression of BMP4 and BMP-dependent genes
(4,25,32). We therefore addressed also the ability of
ZFHX1BAZmut proteins to repress expression driven from
XBMP4 promoter-based reporter constructs in HEK293T
cells. While wild-type ZFHX1B proteins repressed XBMP4
reporter constructs in a concentration-dependent manner, the
repression activity of ZFHX1BAZmut proteins on this reporter
construct was significantly reduced (Fig. 6B).To further inves-
tigate a role for NuRD in XZfhx1b-neuralizing activity, we
used a loss-of-function approach involving previously used
XMi-2b anti-sense MOs (28). Both the XZfhx1b-dependent
repression of BMP4 and the BMP-dependent gene XVent-1,
and the Zfhx1b-mediated induction of the neural marker
N-CAM were reduced in animal cap explants derived from
XMi-2b MOs-injected Xenopus embryos (Fig. 6C).
Co-injection of standard control MOs did not reduce
XZfhx1b activities to a similar extent. We therefore conclude
that endogenous XMi-2b is required for XZfhx1b neuralizing
activity. Co-injection of hMi-2b RNA failed to rescue
XZfhx1b activity in the animal caps derived from XMi-2b
MOs injected embryos (Fig. 6B). Most likely, this is due to
the mesoderm inducing activity seen upon Mi-2b overexpres-
sion, as described for XMi-2 b recently (28).
DISCUSSION
Although the defects in neural crest and neurogenesis in con-
ventional Zfhx1b knockout mice helped to explain the devel-
opmental defects that relate to certain clinical features of
MWS patients, the precise molecular mechanism(s) under-
lying this congenital disorder is still unknown. Here, we fol-
lowed a proteomics approach and identified multiple
subunits of the NuRD complex as novel nuclear partners for
Zfhx1b. We confirmed association of endogenous Zfhx1b
with endogenous NuRD, and demonstrated that this interaction
is mediated via the N-terminal domain of Zfhx1b, which
harbors a recently defined NuRD-interacting motif. NuRD
association has been reported for multiple transcriptional
repressors, including Ikaros (33), KAP-1 (34), p53 (35),
Bcl-6 (36), FOG-1 (37) and BCL11B (38). Previous purifi-
cations of the NuRD complex did not identify Zfhx1b proteins
(18–21). This suggests that Zfhx1b is not a bona fide com-
ponent of this complex but rather transiently associates, poss-
ibly depending on the cell type or its activation status, with
NuRD to regulate transcription of a selective set of Zfhx1b
target genes. In addition, previous searches for proteins con-
taining the proposed NuRD-interaction motif yielded neither
Zfhx1b nor dEF1 (Zfhx1a) (30,37). The reason may be
2-fold. First, all C2H2 type zinc finger transcriptional repres-
sors that also interact with NuRD, such as Friend of GATA
proteins (FOG-1 and FOG-2), Chicken Ovalbumin Upstream
Promoter Transcription Factor Interacting Proteins (CTIP1
and CTIP2) and zinc finger protein 423 (Ebfaz), contain the
motif at their extreme N-terminal end, whereas in Zfhx1b 11
amino acids unrelated to the proposed motif precede it.
Second, the motif is in fact not strictly conserved within
Figure 3. A dominant-negative variant of Mi-2b interferes with Zfhx1b-mediated repression of specific target promoters in reporter constructs. HEK293T cells
were transiently transfected with constructs coding for Zfhx1b, wild-type or mutant Mi-2bK750C polypeptides, and the E-cadherin (A), or 3TPlux reporter con-
structs (B). Cells were harvested 48 h after transfection and were analyzed for luciferase activity. b-galactosidase activity corrected luciferase values are given.
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Zfhx1b but still contains the critical residues found within
Sall1 (30).
Patients presenting with typical MWS all carry either whole
gene deletions or a translocation, nonsense mutation or a
frame shift mutation in one allele (12). The clear lack of a cor-
relation between the genotype and the clinical features of the
patients previously suggested ZFHX1B haplo-insufficiency as
the major mechanism causing MWS (39). Here, we present
evidence suggesting that defective NuRD recruitment by
ZFHX1B is implicated in the etiology of at least a mild
form of MWS. First, a ZFHX1B protein, similar to the aber-
rant ZFHX1B protein in a patient presenting with atypical
MWS (16), is unable to interact with NuRD. This aberrant
protein in this patient is identical to the wild-type protein
from amino acid 25 onwards, and therefore retains both zinc
finger clusters required for DNA-binding and all previously
Figure 5. Defective NuRD recruitment by a mutant ZFHX1B protein that
causes atypical MWS. (A) Alignment of Sall1, Zfhx1a, mouse, Xenopus
laevis and human wild-type Zfhx1b, and mutant ZFHX1B amino-terminal
domains. The conserved 12 amino acid motif (italics) in Sall1 that is sufficient
for NuRD recruitment and the critical residues () that abolished binding to
NuRD and repression by Sall1 when mutated are indicated. Note that mouse
Zfhx1a and mouse, human and Xenopus laevis Zfhx1B but not the Atypical
Zweier mutant human Zfhx1b contain the conserved motif (bold) within
their N-terminus. (B) Schematic presentation of the ZFHX1BWT and
ZFHX1BAZmut proteins used in this study. (C) Western-blot detection
showing co-immunoprecipitation of endogenous NuRD subunits with
ZFHX1BWT but not ZFHX1BAZmut. Note that CtBP binding by ZFHX1BAZmut
proteins is unaffected.
Figure 4. Zfhx1b associates with NuRD via its N-terminal domain. (A)
Graphic presentation of wild-type (WT) full-length (FL) and mutant Zfhx1b
proteins used in this study. (B) Western-blot detection showing
co-immunoprecipitation of Flag-MTA2 and RbAp48, and HA-HDAC2 with
the respective Zfhx1b proteins (triangle) tested.
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known interaction domains for non-NuRD proteins in Zfhx1b
(16). Second, we found that the repression of E-cadherin pro-
moter constructs by Zfhx1b is less efficient in the presence of
a dominant-negative form of Mi-2b. Third, XZfhx1b fails to
efficiently induce a neural program in the absence of endogen-
ous XMi-2b in frog embryos, which might be relevant regard-
ing the neurological problems seen in MWS patients. Fourth,
we found that the ability of ZFHX1BAZmut proteins to
repress expression driven from a XBMP4 promoter reporter
construct is reduced compared to ZFHX1BWT proteins.
Given the apparent specificity with which Zfhx1b and NuRD
act together to selectively regulate promoters, this may very
well explain the milder phenotype. We have shown previously
that CtBP-mediated repression is only one of the mechanisms
underlying Zfhx1b action, as observed in both Zfhx1b-induced
neurogenesis in Xenopus (25) and E-cadherin repression (10).
In line with this, multiple repression modes have also been
reported for other transcriptional zinc finger repressors that
recruit CtBP, including Knirps and FOG (40–42). The AZ
patient still contains one functional ZFHX1B allele and the
ZFHX1BAZmut protein misses only the first 24 amino acids.
Hence, the resulting protein still contains all previously
characterized domains, including a functional CtBP interact-
ing domain (also shown in Fig. 5C). It is interesting to note
that this patient has characteristic facial appearance but
speaks full sentences. This indicates that the patient has
also neural crest cell deficiencies, but the condition of
mental retardation is quite different from that of typical
MWS patients, who have severe mental retardation and limit-
ation of language. Based on the presence of a potential N-
myristoylation site within the highly evolutionary conserved
N-terminal region affected in the AZmut patient, a
critical role of ZFHX1B N-myristoylation in neural crest
cell differentiation and migration was previously discussed
(16). Our work, however, strongly supports a role for NuRD
ZFHX1B association in neural crest cell development.
Hence, the production of an aberrant ZFHX1B protein
lacking the putative NuRD interacting motif within its
N-terminal region but containing all previously characterized
functional domains may well explain the clinical condition
of the AZmut patient.
Given the evidence of NuRD-Zfhx1b association at physio-
logical levels presented here, and the effect of XMi-2b knock-
down on XZfhx1b activity in a process previously used to
document Zfhx1b activity, our work strongly supports a role
for the NuRD complex as a corepressor for XZfhx1b activity,
at least during neural tissue formation. Consistent with this, we
previously found that this XZfhx1b activity is sensitive to the
HDAC inhibitor Trichostatin A (25). In addition to the very
recently discovered role of Mi-2b in the positioning of the
mesodermal/neurectodermal boundary by controlling on its
turn XZfhx1b transcripts (28), we show here a new aspect of
Mi-2b as being a partner of Zfhx1b during early neural amphi-
bian development. Taken together, our study provides new
Figure 6. XZfhx1b depends on intact XMi-2b activity in early neural tissue formation. (A) Whole-mount in situ hybridization with a cRNA probe for XZfhx1b
and XMi-2b at the indicated developmental stages; ba, branchial arches; ev, eye vesicle; nc, neural crest; nt, neural tube; s, somites. (B) The indicated plasmids
were transfected into HEK293T cells and cells were analyzed 48 h later for the XBMP4 promoter-driven luciferase activity. b-Galactosidase-corrected luciferase
values are given. Note that ZFHX1BWT represses the activity of the reporterconstruct in a dose-dependent manner, while repression by ZFHX1BAZmut proteins is
significantly reduced. (C) QRT–PCR expression analysis of the indicated genes on total RNA isolated from animal caps derived from embryos injected with
XZfhx1b RNA alone (200 pg/blastomere), co-injected with MOs against XMi-2b, co-injected with MOs against XMi-2b and hMi-2b RNA, co-injected with
control MOs, or non-injected. Values were corrected for H4. Note that overexpression of XZfhx1b represses XBMP4 and the BMP-dependent gene XVent-1
and induces the neural gene N-CAM, while knock-down of XMi-2b alleviates XZfhx1b-dependent repression and induction of the respective genes.
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molecular insight into XZfhx1b neural inducing activity,
which depends on its N-terminal domain and on interaction
with NuRD. Finally, this study, which links a biochemical
approach with mutation analysis in MWS patients, suggests
that subtle mutations leading to milder or atypical MWS can
be informative for the function of individual domains of the
multi-domain Zfhx1-type proteins. Such more subtle
mutations can in principle be introduced in mouse embryonic
stem cells within the Zfhx1b gene itself for testing their effect
on embryogenesis or postnatal development.
MATERIALS AND METHODS
Plasmids
The mouse 3XFS-Zfhx1b expression construct was generated
by insertion of a strep tag encoding double-stranded oligonu-
cleotide (AGCTTATGGCTAGCTGGAGCCACCCGCAGTT
CGAAAAAGGCG) between the HindIII and EcoRI site of
p3XFLAG-CMV-7.1 (Sigma), and subcloning of the full
open reading frame of mouse Zfhx1b in frame with the
N-terminally 3XFS tag (using BglII and EcoRV restriction
sites). Constructs encoding Zfhx1b mutants were generated
by subcloning the Zfhx1b cDNA fragments (eventually corre-
sponding with amino acids 1–289, 1–317, 1–436, 1–493, 1–
714 and 715–1214) in-frame with six Myc tags and the
nuclear localization signal of SV40 T-antigen in pCS2-
NLS-Myc. The cDNA encoding human ZFHX1B was first
subcloned into pPCR-Script and via EcoRV and SmaI restric-
tion digestion inserted into p3XFS (cut with EcoRV). The
ZFHX1BAZmut was generated by insertion of selected double-
stranded oligonucleotides containing the sequences as
described (16). pCDNA3.1-FLAG-MTA2 and -RbAp48 were
generated by insertion of the MTA2 and RbAp48 coding
regions (pCMV Sport6 MTA2/RbAp48; Open Biosystems)
into pCDNA3.1-FLAG. pMT2-HA-HDAC2 was received
from S. Schreiber[0]. Constructs used in luciferase assays
are the pGL3 wild-type E-cadherin promoter(2178þ44)-
luciferase reporter (22) and the p3TPLux reporter (23). From
the 2 Kb-long XBMP4 (22000 to þ54) promoter-based luci-
ferase reporter (received from W. Knochel), a 488 bp-long
promoter fragment was amplified and cloned into pGL4.16.
A cytomegalovirus promoter-driven lacZ reporter was used
for normalization. pCMVSport6 with inserts of wild-type
mouse Mi-2b and mutant mouse Mi-2bK750C cDNA were
a kind gift from J. Svaren (Wisconsin-Madison; USA). The
pCMV Sport6 hMi-2b was obtained from Open Biosystems.
Constructs used in this study that have been described else-
where are pCS2 with inserts of 6Myc-tagged wild-type
mouse (5) and Xenopus Zfhx1b cDNA (24).
Cell culture and transient transfections
HEK293T cells were cultured in DMEM (Invitrogen) with
10% fetal bovine serum. Transient transfections for associ-
ation studies were done with 25 kDa branched polyethylenei-
mine (PEI; Aldrich), using 4 ml of 1 mg of PEI/ml of stock
solution per mg of DNA, unless stated elsewhere. Reporter
assays were done according to van Grunsven et al. (25)
using 7.5  104 cells per well of a 96-well plate.
Immunoprecipitations
For double affinity purification, HEK293T cells were seeded
in 9 cm cell culture dishes (2  106 cells/dish) and transiently
transfected after 24 h with 3XFS-tag or 3XFS-Zfhx1b-
encoding plasmids. Cells were harvested 1 day later, washed
twice with ice-cold phosphate-buffered saline and incubated
for 20 min on ice with lysis buffer (170 mM NaCl, 10 mM
EDTA, 50 mM Tris pH 7.4, 50 mM NaF, 0.2 mM dithiothreitol
and 0.5% NP-40) supplemented with protease and phosphatase
inhibitors. Lysates were collected by centrifugation (21.000 g
for 20 min at 48C). Supernatant was incubated with avidin
(Biochemika) (48C, 1 h) and avidin complexes were collected
by centrifugation (20 min, 48C). Extracts were subjected to
affinity purification by overnight incubation with M2 anti-
FLAG agarose beads (Sigma) on a rotating wheel at 48C.
Beads were washed and complexes were eluted by compe-
tition with 3XFLAG peptides (Sigma) (3 h, 48C). Extracts
were applied to a streptactin-agarose column for a second puri-
fication (carried out according to the manufacturer’s protocol;
IBA), and precipitated by incubation with two volumes of
ice-cold acetone at 2208C. Semi-endogenous immunoprecipi-
tation (IP) was done according to the conditions described for
the tandem affinity purification, except for the avidin incu-
bation, which was omitted here. Flag-affinity purified com-
plexes were precipitated using acetone.
Co-IP. Whole cell extracts were precleared for 30 min using
Protein G-Sepharose beads (Amersham Biosciences) and pre-
cipitated overnight at 48C on a rotating wheel using antibodies
against Myc (Santa Cruz) or Flag (Santa Cruz). Complexes
were precipitated with blocked protein G Sepharose beads.
For endogenous IP, HEK293T cells were plated in T-175
flasks and precipitation was carried out as described for
co-IP. Precleared lysates were precipitated with anti-Zfhx1b
rabbit polyclonal antiserum (10) and anti-Flag (Santa Cruz)
antibodies. Antibodies used in western blotting detected
CtBP (Sigma), Flag (Sigma), HDAC1 (Santa Cruz), HDAC2
(Santa Cruz), Mi2 (Santa Cruz), MTA-1 (Santa Cruz),
MTA-2 (Santa Cruz), p66 (Upstate), RbAp46 (Santa Cruz),
RbAp48 (Abcam) and Zfhx1b (10), respectively.
Mass spectrometry analysis
Purified Zfhx1b complexes were denatured for 5 min and sub-
jected to gel electrophoresis. Staining of the gel was done with
Brilliant Blue G-colloidal concentrate (Sigma), and bands
were excised and subjected to MS (26). A nano-scale C18
reversed phase peptide separation system, on-line connected
with the ion source of a Q-TOF1 mass spectrometer, was
used (Micromass UK Cheshire, UK). Peptides were identified
from their fragmentation spectra using the MASCOT search
engine and the Swiss-Prot database. Peptides identified by a
MASCOT score that exceeded the identity threshold score of
MASCOT at the 95% confidence level were considered as
positively identified.
Xenopus manipulations and injections
Embryos were obtained from adult frogs by hormone-induced
egg-laying and in vitro fertilization using standard methods
Human Molecular Genetics, 2008, Vol. 17, No. 8 1181
(27). Capped transcripts were synthesized in vitro using the
mMessage mMachine kit (Ambion, Austin, TX, USA) and
injected in the animal hemisphere of all blastomeres of four
cell stage embryos. Animal cap explants were prepared at
late blastula stage (stage 9.5) and cultured in 1 Steinberg
medium supplemented with 0.1% bovine serum albumin
(Steinberg) until early neurula stage. The XMi-2b and stan-
dard control morpholino oligonucleotides (MOs) were
obtained from Gene Tools LLC and are described elsewhere
(28).
In situ hybridization
Embryos were fixed in MEMFA, stained for b-galactosidase
activity with 5-bromo 4-chloro-3-indolyl-b-galactopyranoside
(X-Gal) and processed for in situ hybridization using
digoxygenin-labeled antisense RNA probes (27). Production
of the probe for detection of XZfhx1b transcripts has been
described elsewhere (24).
Real-time RT–PCR
The Qiagen RNeasy mini kit was used for RNA isolation from
animal caps at stage 10. All RNA preparations were treated
with DNAse I (Qiagen). Real-time RT–PCR was performed
on an ABI PRISM 7700 (Applied Biosystems) using Platinum
SYBR Green qPCR SuperMix-UDG (Invitrogen). The follow-
ing primers were used: BMP4 (F) 50-GAGATTGTCCATT
TCCCTTGGC-30, (R) 50-TCAGTGGAAAGAAGTCCAGC
CG-30; Histone H4, (F) 50-CAAGCGCATCTCAGGTCTC
AT-30, (R) 50-ACCTTGAGAACGCCACGAGT-30; N-CAM
(43); XVent1, (F) 50-CGATCCAACTCTACAGCCCC-30, (R)
50-GGGACTCAGAGATACGGAGGC-30.
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